These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7777267)

  • 1. Blood glucose control and vision outcome in diabetes.
    Minckler D
    Ophthalmology; 1995 May; 102(5):703-4. PubMed ID: 7777267
    [No Abstract]   [Full Text] [Related]  

  • 2. Cotherapy with recombinant human IGF-I and insulin improves glycemic control in type 1 diabetes.
    Lanzetta P; Malara C
    Diabetes Care; 2000 Mar; 23(3):436-7. PubMed ID: 10868894
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes control and complications. Where do we go from here?
    Ratner RE
    Online J Curr Clin Trials; 1993 Jun; Doc No 68():[996 words; 6 paragraphs]. PubMed ID: 8313018
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of diabetic control on diabetic retinopathy.
    Kohner EM
    Eye (Lond); 1993; 7 ( Pt 2)():309-11. PubMed ID: 7607352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of insulin-dependent diabetes: hypoglycaemia and the eye.
    Frier BM
    Eye (Lond); 1993; 7 ( Pt 2)():293-7. PubMed ID: 7607349
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1995 Jan; 113(1):36-51. PubMed ID: 7826293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worsening of diabetic retinopathy after improvement of glycemic control.
    Davis MD
    Arch Ophthalmol; 1998 Jul; 116(7):931-2. PubMed ID: 9682709
    [No Abstract]   [Full Text] [Related]  

  • 8. Retinopathy in patients with type 1 diabetes 4 years after intensive therapy.
    Bressler SB; Bressler NM
    Arch Ophthalmol; 2000 Jul; 118(7):984-5. PubMed ID: 10910526
    [No Abstract]   [Full Text] [Related]  

  • 9. Colour vision in long-standing diabetes mellitus.
    Roy MS; McCulloch C; Hanna AK; Mortimer C
    Br J Ophthalmol; 1984 Mar; 68(3):215-7. PubMed ID: 6696875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of visual functions in young insulin dependent diabetics.
    Banford D; North RV; Dolben J; Butler G; Owens DR
    Ophthalmic Physiol Opt; 1994 Oct; 14(4):339-46. PubMed ID: 7845689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefits of tight glycemic control in diabetes mellitus. For the many or for the few?
    Brancati FL
    Arch Intern Med; 1995 Apr; 155(7):665-7. PubMed ID: 7695453
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications of the Diabetes Control and Complications Trial. American Diabetes Association.
    Diabetes; 1993 Nov; 42(11):1555-8. PubMed ID: 8405694
    [No Abstract]   [Full Text] [Related]  

  • 13. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    Ophthalmology; 1995 Apr; 102(4):647-61. PubMed ID: 7724182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 diabetes: benefits of intensive insulin therapy. Patients should control blood glucose strictly.
    Prescrire Int; 2002 Apr; 11(58):61. PubMed ID: 11987320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
    Klein R; Moss SE; Klein BE; Gutierrez P; Mangione CM
    Arch Ophthalmol; 2001 May; 119(5):733-40. PubMed ID: 11346401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does normalization of blood glucose reduce the complications of diabetes?
    Vajdos MA; Gilliland PF
    South Med J; 1995 Mar; 88(3):372-5. PubMed ID: 7886542
    [No Abstract]   [Full Text] [Related]  

  • 17. Determinants of retinopathy progression in type 1 diabetes mellitus.
    Cohen RA; Hennekens CH; Christen WG; Krolewski A; Nathan DM; Peterson MJ; LaMotte F; Manson JE
    Am J Med; 1999 Jul; 107(1):45-51. PubMed ID: 10403352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular recovery function (nyctometry) in diabetics without and with early retinopathy.
    Midena E; Segato T; Giuliano M; Zucchetto M
    Br J Ophthalmol; 1990 Feb; 74(2):106-8. PubMed ID: 2310723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual function in diabetic patients undergoing dialysis: comparison of peritoneal and hemodialysis.
    Diaz-Buxo JA; Burgess WP; Greenman M; Chandler JT; Farmer CD; Walker PJ
    Int J Artif Organs; 1984 Sep; 7(5):257-62. PubMed ID: 6500731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular hyperperfusion following onset of intensified insulin therapy is inversely correlated with plasma endothelin-1 in Type I diabetes.
    Fuchsjäger-Mayrl G; Kautzky-Willer A; Kiss B; Roden M; Wagner O; Pleiner J; Wolzt M; Schmetterer L
    Diabetologia; 2002 Jun; 45(6):883-9. PubMed ID: 12107733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.